Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeep B J Reddy

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesionsNaveen K Rajasagi, Amol Suryawanshi, Sharvan Sehrawat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2011
Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitisSachin Mulik, Shalini Sharma, Amol Suryawanshi, et al.
The American Journal of Pathology|June 5, 2012
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virusSachin Mulik, John Xu, Pradeep B J Reddy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2014
Critical role of microRNA-155 in herpes simplex encephalitisSiddheshvar Bhela, Sachin Mulik, Pradeep B J Reddy, et al.
The American Journal of Pathology|February 22, 2015
Role of miR-155 in the pathogenesis of herpetic stromal keratitisSiddheshvar Bhela, Sachin Mulik, Fernanda Gimenez, et al.
Frontiers in Immunology|August 8, 2022
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus MacaquesTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Journal of Virology|July 20, 2012
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesionsPradeep B J Reddy, Taylor H Schreiber, Naveen K Rajasagi, et al.
Journal of Virology|July 26, 2019
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus ChallengeTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Frontiers in Immunology|February 4, 2020
Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus InfectionAmudhan Murugesan, Chris Ibegbu, Tiffany M Styles, et al.
Journal of Virology|January 18, 2019
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope VariantsSamantha Burton, Lori M Spicer, Tysheena P Charles, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesionsNaveen K Rajasagi, Amol Suryawanshi, Sharvan Sehrawat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2011
Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitisSachin Mulik, Shalini Sharma, Amol Suryawanshi, et al.
The American Journal of Pathology|June 5, 2012
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virusSachin Mulik, John Xu, Pradeep B J Reddy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2014
Critical role of microRNA-155 in herpes simplex encephalitisSiddheshvar Bhela, Sachin Mulik, Pradeep B J Reddy, et al.
The American Journal of Pathology|February 22, 2015
Role of miR-155 in the pathogenesis of herpetic stromal keratitisSiddheshvar Bhela, Sachin Mulik, Fernanda Gimenez, et al.
Frontiers in Immunology|August 8, 2022
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus MacaquesTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Journal of Virology|July 20, 2012
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesionsPradeep B J Reddy, Taylor H Schreiber, Naveen K Rajasagi, et al.
Journal of Virology|July 26, 2019
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus ChallengeTiffany M Styles, Sailaja Gangadhara, Pradeep B J Reddy, et al.
Frontiers in Immunology|February 4, 2020
Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus InfectionAmudhan Murugesan, Chris Ibegbu, Tiffany M Styles, et al.
Journal of Virology|January 18, 2019
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope VariantsSamantha Burton, Lori M Spicer, Tysheena P Charles, et al.
Pageof 3